ERBB2 and neoplasm: Based on this mechanism, one of the anticancer mechanisms of ALA involves reducing tumor cell activity at the TKR level and inhibiting tumor cell proliferation mediated by the oncogenes ERBB1/EGFR and ERBB2/HER2.